Community Health Promotion for COVID-19 Prevention and NCD Risk Reduction in Rural Sri Lanka
Community Empowerment for COVID-19 Prevention and Non-Communicable Disease Risk Reduction Using a Health Promotion Approach: A Mixed-Methods Community Intervention Study From Rural Sri Lanka
This study evaluated a community health promotion programme, funded by the World Health Organization Sri Lanka Country Office, that addressed COVID-19 prevention and household non-communicable disease (NCD) risk together in six rural villages of Alawwa Divisional Secretariat, Kurunegala District, Sri Lanka, between December 2020 and April 2021. Community groups followed a four-step community-based health promotion process and co-designed three monitoring tools (the Corona Calendar, the Kussi [kitchen] Calendar and the Happiness Calendar). The study describes self-rated household NCD risk before and after initial sessions, baseline waist circumference and kitchen dietary risk, practices reported by families at programme end, and community members' experiences.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Seven initial sessions (one in each of six villages and one with a children's group; 246 participants) were followed by 17 follow-up contacts by health promotion facilitators through home visits, telephone and social media. The programme followed four steps: identifying prevention of COVID-19 spread as a collective goal; understanding the determinants of COVID-19 spread and NCD risk; identifying and prioritising actions; and implementing and monitoring actions using indicators agreed with the community.
Data were recorded in aggregated, village-level form: session-mean self-ratings of household NCD risk (0 to 10, 10 = highest risk) at the start and end of the initial session; baseline waist circumference classified against South Asian cut-off points; household kitchen risk classified by the Kussi Calendar (oil, sugar, salt and rice); and counts of families and community members reporting practices at programme end, obtained by telephone and a group discussion. Audio-recorded group discussions in Sinhala were translated into English and analysed thematically.
The study was single-arm with no comparison group, and all analyses were descriptive.
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Western Province
-
Alawwa, North Western Province, Sri Lanka, 10640
- Alawwa Divisional Secretariat area (six community villages)
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Resident of one of the six programme villages (Galoliyawa, Welikare, Nallura, Boyawalana, Henduwawa or Pangolla) in Alawwa Divisional Secretariat, Kurunegala District, Sri Lanka
- Chose to take part in the community health promotion programme
Exclusion Criteria:
- None
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Community health promotion programme
Community members of six villages and a children's group who took part in the initial sessions and community groups. |
Initial session on COVID-19 transmission and prevention, the link between NCDs and severe COVID-19, NCD risk factors, family happiness and home gardening; formation of community groups; follow-up contacts by health promotion facilitators; and community co-designed monitoring tools (Corona, Kussi and Happiness Calendars), following a four-step community-based health promotion process. |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-rated household NCD risk
Time Frame: Day 1 (immediately before and immediately after the initial session)
|
Session-mean rating by participants of the risk of non-communicable diseases in their own home on a scale of 0 (lowest risk) to 10 (highest risk), recorded at the start and end of the initial session. |
Day 1 (immediately before and immediately after the initial session)
|
|
Proportion of active families reporting COVID-19 preventive practices
Time Frame: Up to 5 months (end of programme)
|
Number of active families reporting a household handwashing place, removing slippers or changing clothes before entering the house, as a proportion of active families in each village. |
Up to 5 months (end of programme)
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion of active families reporting dietary changes
Time Frame: Up to 5 months (end of programme)
|
Number of active families reporting reduced consumption of oil, sugar, salt, flour or junk food, or checking E-numbers on packaged food, as a proportion of active families in each village. |
Up to 5 months (end of programme)
|
|
Community members reporting weight reduction
Time Frame: Baseline (Day 1) to 5 months (end of programme)
|
Number of community members who monitored their weight and reported a reduction. |
Baseline (Day 1) to 5 months (end of programme)
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Waist circumference above cut-off
Time Frame: Baseline
|
Proportion of participants with waist circumference above the cut-off (women more than 80 cm; men more than 90 cm). |
Baseline
|
|
Household kitchen NCD risk classification
Time Frame: Baseline
|
Proportion of households classified red, orange or green by the Kussi Calendar according to consumption of oil, sugar, salt and rice against household-agreed levels. |
Baseline
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pathologic Processes
- Nutrition Disorders
- Disease Attributes
- Overnutrition
- Body Weight
- Respiratory Tract Infections
- Infections
- RNA Virus Infections
- Virus Diseases
- Respiratory Tract Diseases
- Lung Diseases
- Pneumonia, Viral
- Pneumonia
- Coronavirus Infections
- Coronaviridae Infections
- Nidovirales Infections
- Overweight
- Obesity
- Pathological Conditions, Signs and Symptoms
- Nutritional and Metabolic Diseases
- Signs and Symptoms
- COVID-19
- Noncommunicable Diseases
- Obesity, Abdominal
Other Study ID Numbers
Other Study ID Numbers
- ERC/03/20
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Only aggregated, village-level data were recorded during the programme; no individual-level participant data exist to share.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.